OMCM News 0.1600 Omnicomm Systems Inc (OMCM)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Omnicomm Systems Inc (OMCM) 0.1600 $OMCM

Surrey Clinical Research Centre Signs a Five Year Agreement for OmniComm Systems' R) Promasys(R) Software
Marketwire - Mon Apr 14, 7:03AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM) a leading global provider of clinical data management solutions for clinical trials, announced the signing of a five year agreement for its Promasys investigator initiated trials (IITs) technology with Surrey Clinical Research Centre (Surrey CRC) at the University of Surrey, a UK based research center focused on the design and execution of Phase I and IIa trials in sleep, psychopharmacology, oncology, immunology and vaccines.

Leading Specialty Pharmaceutical Company Selects OmniComm Systems(R), Inc. TrialMaster(R) to Support Novel Medical Research
Marketwire - Mon Apr 07, 6:01AM CDT
A leading US specialty pharmaceutical company focused on the development and commercialization of novel medicines has selected OmniComm Systems, Inc.'s (OTCQB: OMCM), TrialMaster for three clinical studies comprising a Phase II, Phase III, and safety and pharmacokinetic study.

OmniComm Systems expands market presence in Asia
M2 - Fri Apr 04, 7:00AM CDT
OmniComm Systems, Inc. (OTC: OMCM) said it has signed a five-year agreement with Seoul National University Hospital Clinical Trials Center to use OmniComm Systems' market leading TrialOne technology for automation within its Phase I clinical pharmacology studies.

Seoul National University Hospital Signs Five Year Agreement With OmniComm Systems(R) TrialOne(R) for Clinical Research Automation
Marketwire - Thu Apr 03, 6:01AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management solutions for clinical trials, signed a five year agreement with Seoul National University Hospital (SNUH) Clinical Trials Center, a leading academic medical center in the Republic of Korea, to use OmniComm Systems' market leading TrialOne technology for automation within its Phase I clinical pharmacology studies.

OmniComm(R) Systems Announces Major Milestone Achievement of Over 4,000 Clinical Trials
Marketwire - Tue Mar 25, 6:01AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management solutions for clinical trials, today announced its electronic data capture (EDC) solutions have been used in more than 4,000 live or completed clinical trials in over 55 countries across more than 30 therapeutic areas. The company's EDC solutions are widely accepted and utilized by pharmaceutical; biotechnology; contract research organizations; academic research centers and medical device companies of all sizes in all clinical trial phases. OmniComm's EDC technologies are embraced by the industry by significantly streamlining clinical processes through innovation, automation and interoperability.

Centre for Human Drug Research Selects OmniComm(R) Promasys(R) Mobile Technology
Marketwire - Wed Mar 19, 6:00AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM) signed a five year agreement with Centre for Human Drug Research (CHDR), a clinical research center in The Netherlands, for Promasys mobile electronic data capture (EDC) technology. This agreement gives CHDR the ability to capture data right at the point-of-clinical testing utilizing the latest in mobile technology.

OmniComm(R) Systems Signs $2.5 Million Deal With Major Biotechnology Company
Marketwire - Mon Mar 17, 1:41PM CDT
OmniComm Systems, Inc. (OTCQB: OMCM) signed a $2.5 million contract for one Phase II and four Phase III global studies with a major east coast biotechnology company to supply OmniComm's market leading electronic data capture (EDC) technology, TrialMaster 4.2. TrialMaster EDC was selected in part for its award-winning Custom Data Export Utility. This enables compliance with FDA's, soon to be mandated, requirement for all clinical data submissions to conform to the Study Data Tabulation Model (SDTM). Conventional methodologies, used for clinical data submission, are very costly and typically take months to complete. TrialMaster's Custom Data Export Utility significantly decreases time to submission and can have SDTM data sets ready within 48 hours of database lock. TrialMaster's unique capability converts clinical study data to SDTM formats during trial conduct in real time, resulting in lower costs, decreased cycle times, and reduced rework.

OmniComm Systems, Inc. Announces Major New Release of TrialMaster(R) EDC
GlobeNewswire - Mon Dec 30, 11:28AM CST
OmniComm Systems, Inc. (OTC:OMCM), today announced the production availability of Version 4.2 of TrialMaster, its flagship product for Electronic Data Capture (EDC). This new release includes hundreds of innovative productivity and functionality enhancements, including additional features for auto-redaction for faster and more efficient centralized and risked-based monitoring, and major new features for exporting data utilizing OmniComm's award winning Export Utility.

OmniComm Systems Ranks Number 481 on Deloitte's 2013 Technology Fast 500(TM) for Fastest Growing Companies in North America
GlobeNewswire - Thu Dec 26, 10:55AM CST
OmniComm Systems, Inc. (OTC:OMCM), today announced that it was ranked number 481 on Deloitte's Technology Fast 500(TM), a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America over the past 5 years. OmniComm Systems' revenue grew 148 percent over this period.

OmniComm Systems, Inc. Celebrates Innovation and Excellence at Third Annual Innovation Forum
GlobeNewswire - Fri Nov 22, 7:30AM CST
OmniComm Systems, Inc. (OTC:OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, celebrated innovation and excellence at their annual Innovation Forum in Ft. Lauderdale last week.

OmniComm Systems, Inc. Acquires Promasys BV
GlobeNewswire - Tue Nov 12, 7:30AM CST
OmniComm Systems, Inc. (OTC:OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced the acquisition of Promasys BV, a privately held Netherlands based company dedicated to the development and marketing of clinical trial software and related services designed specifically for academic research and investigator initiated trials.

OmniComm Bolsters Organization With Addition of Two Industry Experts
GlobeNewswire - Mon Nov 11, 11:45AM CST
John Fontenault Joins as Vice President of Operations

Clinverse, Inc. Announces Strategic Partnership With OmniComm Systems, Inc.
PRWeb - Wed Sep 04, 9:03AM CDT
Clinverse, Inc., a global technology and eclinical commerce network for clinical trials, announced today it has formed a strategic partnership with OmniComm Systems, Inc., a leading provider of EDC solutions.

Top 5 Pharma Company Chooses OmniComm System's TrialMaster(R) EDC Solution for Late Phase Research
GlobeNewswire - Wed Aug 14, 7:30AM CDT
OmniComm Systems, Inc. (OTC:OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that its TrialMaster(R) EDC solution has been selected by a top 5 pharmaceutical company to run a 5 year late-phase, non-interventional oncology trial.

Inflamax Research commits to use OmniComm eClinical Suite
M2 - Wed Jul 10, 10:09AM CDT
OmniComm Systems, Inc. (OTC: OMCM) said that Inflamax Research has made a five-year commitment to utilize OmniComm's eClinical Suite to further enhance their clinical operations.

Inflamax Research Selects OmniComm Systems' eClinical Suite to Enhance Clinical Operations
GlobeNewswire - Tue Jul 09, 8:03AM CDT
OmniComm Systems, Inc. (OTC:OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced that Inflamax Research, a full service Contract Research Organization (CRO), has made a 5 year commitment to utilize OmniComm's eClinical Suite to further enhance their clinical operations.

OmniComm Systems, Inc. Appoints Kuno van der Post, Ph.D. as Senior Vice President of Business Development
GlobeNewswire - Mon Jun 24, 7:30AM CDT
OmniComm Systems, Inc. (OTC:OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that Kuno van der Post, Ph.D. has been promoted to Senior Vice President of Business Development.

OmniComm Systems, Inc. and Soltex Consulting, LLP Announce a Strategic Partnership
GlobeNewswire - Mon Jun 17, 8:05AM CDT
OmniComm Systems, Inc. (OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, and Soltex Consulting, LLP, a leading eClinical lifecycle consulting firm, announced their new strategic partnership today. The partnership will allow OmniComm to offer best-in-class process reengineering and change management consulting to its EDC software customers, and augment OmniComm's own study build services, while allowing Soltex to offer its clients access to one of the most intuitive, productive EDC suites available on the market today.

E-Clinical Trial Technologies: Oracle Dominates - Global Strategic Business Report 2013-2018
M2 - Fri Jun 14, 9:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dsxrd3/eclinical_trial) has announced the addition of the "E-Clinical Trial Technologies - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for E-Clinical Trial Technologies in US$ Million by the following Product Segments: Electronic Data Capture (EDC) Solutions, Clinical Trial Management System (CTMS), mElectronic Patient Reported Outcome (ePRO), Randomization and Trial Supply Management (RTSM), and Interactive Response Technology (IRT). The report provides separate comprehensive analytics for the US, Canada, Europe, Asia Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The report profiles 112 companies including many key and niche players such as: - Almac Group - ArisGlobal LLC - BioClinica - Clinipace Worldwide - Cmed Technology Ltd. - DATATRAK International, Inc. - DSG Inc. - DZS Software Solutions, Inc. - eClinForce, Inc. - e

Top 5 Pharma Company Signs 5-Year Multi-Million Dollar Agreement for OmniComm System's TrialOne Application Suite
GlobeNewswire - Mon Jun 03, 12:41PM CDT
OmniComm Systems, Inc. (OTC: OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that its TrialOne(R) suite of applications has been chosen by a top 5 pharmaceutical company to automate their global clinical trial operations and processes in all their early-phase clinics.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 151

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading
LONGWELL's New Axial Fan Selection Guide Unveiled

Updated Category News Views 88

LONGWELL's New Fan Brochure Shakes Up Data Center Cooling Alright, let's cut to the chase. LONGWELL, the folks out in Ningbo who live and breathe HVACR and industrial fans, have dropped a new tool that’s going to have OEM engineers raising a glass. This twelve-page axial fan selection guide is a stroke of genius—or at least that's what those of us who've braved the...

Continue Reading
WHP Global's Japan Move: A Major Toy Market Play

Updated Category News Views 113

New Horizons for Toys"R"Us in Japan Well, folks, look who's back in the toy game with a vengeance! WHP Global is shaking hands with Pan Pacific International Holdings (PPIH) to breathe new life into Toys"R"Us across Japan. Now PPIH isn’t just any player. We're talking about Japan's fourth-largest retailer, helming giants like Don Quijote and aiming to crown itself as...

Continue Reading
Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 89

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading
HLTH USA 2026 Spotlights AI and Health Innovation

Updated Category News Views 82

The Pulse of Innovation at HLTH USA 2026 Diving headfirst into the heart of healthcare innovation, HLTH USA 2026 kicked off with gusto in Las Vegas. Discussions are swirling around AI advancements and the next generation of payer-provider collaboration. Who knew healthcare could be this thrilling? The event is already shaping up to be a powerhouse of change, buzzing with...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 122

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 147

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading
Investors, Portillo's Fraud Claims Demand Your Attention

Updated Category News Views 30

Portillo's Investors Caught in a Tough Spot Ah, Portillo's. You thought those hot dogs were the only spicy thing you're biting into? Try these allegations on for size. Investors are biting back with a securities fraud lawsuit, and the details are saltier than a bucket of fries. The folks who held PTLO shares between September 19, 2023, and May 4, 2026, are in the...

Continue Reading
Exploring Why Dead Outlets Stay Dead: Expert Insights

Updated Category News Views 92

The Mystery of Non-Responsive Outlets Ever found an electrical outlet refusing to cooperate when you need it most? Well, I know the frustration all too well. You'd think if the breaker ain't blown, the outlet should work like a charm. But dive into the guts of the story, and you find a series of surprises waiting to trip us up. Common Culprits: Tripped GFCIs and Loose...

Continue Reading
Engrain's Geospatial Innovation Pushes Property Mapping Forward

Updated Category News Views 125

Pushing the Boundaries of Property Mapping How far can you expand the boundaries of property mapping tech? Well, Engrain seems hell-bent on finding out by cranking their innovations up a notch. The Denver-based stalwart in interactive mapping is rolling out some mind-boggling enhancements that could redefine how the multifamily housing sector operates. This isn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Insights: Key Players Ford, McDonald's, and Ferrari

Updated Category News Views 155

Anticipating Earnings Reports from Major Companies As we approach the upcoming earnings reports for several key players in the auto and consumer sectors, attention shifts towards Ford, McDonald's, and Ferrari. Understanding performance in this challenging market has never been more crucial. Each company faces unique circumstances that may influence their financial...

Continue Reading
Parsons Corporation Boosts Share Buyback Authorization to $250M

Updated Category News Views 277

Parsons Corporation Boosts Share Buyback Authorization to $250M Parsons Corporation (NYSE: PSN), a notable player in the national security and global infrastructure sectors, has made a significant decision by increasing its stock repurchase authorization to $250 million. This strategic move, announced recently, is set against the backdrop of robust operating results and...

Continue Reading
India's Foreign Exchange Reserves Show Declining Trends

Updated Category News Views 439

Understanding India's Forex Reserves Decline India's foreign exchange reserves have recently captured attention as they have been on a downward trajectory, marking a notable low. As reported, the reserves fell to $625.87 billion, a level not seen in ten months. This decline represents a significant drop of $8.72 billion in just one week, emphasizing the considerable...

Continue Reading
Efekta Education Ups the Ante with Matt Fisher as CTO

Updated Category News Views 16

AI Veteran Matt Fisher Joins Efekta as CTO You know that moment when an industry veteran steps into a key role and you just feel the tide shifting? That's what we've got on our hands with Efekta Education snapping up Matt Fisher. This isn't just any hire; Fisher's a heavyweight tech player, a regular whiz kid from tech giants like Microsoft and Amazon. He’s been around...

Continue Reading
James River Group Enhances Leadership with New Strategic Appointments

Updated Category News Views 186

James River Group Strengthens E&S Leadership Team PEMBROKE, Bermuda — James River Group Holdings, Ltd. (NASDAQ: JRVR) has taken a significant step forward in its growth strategy with the recent appointments of Georgia Collier and Matt Sinosky to its Excess and Surplus (E&S) leadership team. They will report to Todd Sutherland, the President of E&S, as the company aims...

Continue Reading